title: Uterine sarcoma.
abstract: Sarcomas are rare tumors with unpredictable prognosis. They are treated similarly to endometrial cancers. Little is known of epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas. Because of their rarity, uterine sarcomas are not suitable for screening. Chemoprevention studies might target those at risk for recurrence or a second neoplasm.
authors.affiliation: Department of Gynecologic Oncology, University of Texas M. D. Anderson Cancer Center, Houston, USA.
authors.forename: C F
authors.initials: CF
authors.lastname: Levenback
authors.forename: G
authors.initials: G
authors.lastname: Tortolero-Luna
authors.forename: D K
authors.initials: DK
authors.lastname: Pandey
authors.forename: A
authors.initials: A
authors.lastname: Malpica
authors.forename: V V
authors.initials: VV
authors.lastname: Baker
authors.forename: L
authors.initials: L
authors.lastname: Whittaker
authors.forename: E
authors.initials: E
authors.lastname: Johnson
authors.forename: M
authors.initials: M
authors.lastname: Follen Mitchell
mesh_terms: D014408:Biomarkers, Tumor; D005260:Female; D006801:Humans; D008403:Mass Screening; D012307:Risk Factors; D012509:Sarcoma / Q000453:epidemiology / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D014594:Uterine Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000473:pathology* / Q000628:therapy
chemical_list: D014408:Biomarkers, Tumor